USound and Partners to Deliver Next-Generation Over-the-Counter Hearing Aid

What To Know

  • “We are thrilled to partner with OBO Pro2 and ASE Chung-Li to create a state-of-the-art over-the-counter hearing aid that meets the needs of millions of people suffering from hearing loss worldwide,” said Ferruccio Bottoni, CEO of USound.
  • “We believe that our expertise in hearing aid design combined with USound's advanced audio technology will enable us to deliver a superior product that will make a positive impact on people's lives.

USound, a leading provider of advanced audio solutions, announced today its collaboration with partners to develop and deliver a reference design for a cutting-edge over-the-counter (OTC) hearing aid. The reference design will integrate USound’s newest Kore 4.0 audio module, ASE’s Micro SiP (System-in-Package), and OBO Pro2’s innovative hearing aid design, delivering the most advanced hearing aid in the market.

The partnership combines the strengths of all three companies. USound’s expertise in advanced audio technology and its newest Kore 4.0 module will ensure superior sound quality and performance. ASE Chung-Li provides the most compact Bluetooth Micro SiP, designed specifically for the hearable devices; OBO Pro2, an experienced hearing aid manufacturer, delivers the OTC hearing aid and integrates all components into a sleek and user-friendly device.

“We are thrilled to partner with OBO Pro2 and ASE Chung-Li to create a state-of-the-art over-the-counter hearing aid that meets the needs of millions of people suffering from hearing loss worldwide,” said Ferruccio Bottoni, CEO of USound. “Our Kore 4.0 module combined with ASE’s latest Bluetooth Micro SiP provides a superior audio experience, while OBO Pro2’s expertise in hearing aid design ensures that the device is easy to use and comfortable to wear.”

The reference design enables hearing aid manufacturers to rapidly develop and produce OTC hearing aids that meet the highest standards of performance and reliability. With an estimated 500 million people worldwide suffering from hearing loss, the market for OTC hearing will grow significantly in the coming years.

“Collaborating with Usound that embedded ASE’s Micro SiP to provide a high-quality and reliable hearing aid solution to our customers,” said the CEO of OBO Pro2. “We believe that our expertise in hearing aid design combined with USound’s advanced audio technology will enable us to deliver a superior product that will make a positive impact on people’s lives.”

The reference design will be available to hearing aid manufacturers in the second half of 2023.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy